Table 1 Patient demographics in our study (n = 26)

Sex (%)

    Male

8 (31%)

    Female

18 (69%)

 Median Age

35 (Range 8–60)

Ethnicity (%)

    Asian

10 (38%)

    African/Caribbean

3 (12%)

    Caucasian

3 (12%)

    Other

10 (38%)

Treatment Received

    Prednisolone only

7 (27%)

    Prednisolone and IMT combination

19 (73%)

         Mycophenolate mofetil (MMF)

13

         Azathioprine (Aza)

3

         Cyclosporin A (CsA)

3

         Anti-TNF + other IMT

6

    Average time from steroid initiation to IMT initiation

2.1 months

    Average time to steroid-sparing effect of IMT (Prednisolone ≤ 7.5 mg)

5 months